Register now to save up to $680 on your TechCrunch Disrupt 2026 pass and get a second ticket at 50% off. This offer ends next week on January 30, or once the first 500 tickets are claimed — whichever comes first.

The medical info database has doubled in valuation since last raise in October, despite encroachment from model makers.

Diligent Robotics is a startup that builds robots designed to assist in hospitals by delivering lab samples, supplies, and other tasks. The deal values Diligent's common stock at $29 million.

TechCrunch Disrupt Battlefield 2023 winner BioticsAI announced on Monday that it has received FDA clearance for its AI software that helps detect fetal abnormalities in ultrasound images. 

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

OpenAI and Anthropic have each launched healthcare-focused products over the last week.

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.